Literature DB >> 1497354

Fragmentation of dimyristoylphosphatidylcholine vesicles by apomyoglobin.

J W Lee1, H Kim.   

Abstract

Previously we have reported results of a preliminary study on the micellization of phosphatidylcholine vesicles by apomyoglobin at pH 4 (J. W. Lee and H. Kim, 1988, FEBS Lett. 241, 181-184). The micellization study has been extended here to investigate the effect of the lipid to protein ratio, temperature, size of vesicles, and pH. The pH-dependent study indicated that micellization occurs when the protein assumes either a molten globular or random coil structure. Time-dependent hydrophobic labeling by 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)-diazirine showed that there is an initial increase in contact between the protein and hydrophobic acyl chain of lipid followed by a decrease in the interaction. This may be explained as the initial stage of vesicle aggregation which is subsequently superseded by the fragmentation. These reactions are discussed in term of protein unfolding at low pH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497354     DOI: 10.1016/0003-9861(92)90684-o

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Interactions of apomyoglobin with membranes: mechanisms and effects on heme uptake.

Authors:  Grégory Vernier; Alexandre Chenal; Heidi Vitrac; Roya Barumandzadhe; Caroline Montagner; Vincent Forge
Journal:  Protein Sci       Date:  2007-01-22       Impact factor: 6.725

Review 2.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 3.  Nanodiscs: A toolkit for membrane protein science.

Authors:  Stephen G Sligar; Ilia G Denisov
Journal:  Protein Sci       Date:  2020-11-16       Impact factor: 6.993

Review 4.  Non-viral COVID-19 vaccine delivery systems.

Authors:  Kyung Soo Park; Xiaoqi Sun; Marisa E Aikins; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2020-12-17       Impact factor: 17.873

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.